-- Alcoa, Apollo, Dendreon, Exide, Greenbrier: U.S. Equity Movers
-- B y   K a t i a   P o r z e c a n s k i
-- 2012-01-06T21:30:13Z
-- http://www.bloomberg.com/news/2012-01-06/alcoa-bank-of-america-family-dollar-jazz-rf-micro-u-s-equity-preview.html
Shares of the following companies had
unusual moves in U.S. trading. Stock symbols are in parentheses,
and prices are as of 4 p.m. in  New York .  Alcoa Inc. (AA)   fell 2.1 percent, the biggest drop in
the  Dow Jones Industrial Average , to $9.16. The largest U.S.
aluminum producer will close 12 percent of its global smelting
capacity after the price of the lightweight metal slumped as
global supply exceeds demand.  Apollo Group Inc. (APOL)   rose 5.4 percent to $56.64, the
highest price since May 2010. The operator of the University of
Phoenix and the biggest U.S. for-profit college reported fiscal
first-quarter profit and sales that topped analysts’ estimates
as more new students signed up for classes.  DeVry Inc. (DV)  , a for-profit education company, rallied
6 percent to $41.40, the second-biggest gain in the Standard &
Poor’s 500 Index.  Bank of America Corp. (BAC)   declined 2.1 percent to
$6.18 for the second-biggest loss in the Dow. An Obama
administration official who asked for anonymity denied
speculation that the White House is considering a trillion-
dollar plan to refinance home loans. The bank surged 8.6 percent
yesterday amid speculation the U.S. may introduce a new mortgage
refinancing program.  Best Buy Co. (BBY)   rose 3.3 percent, the most since Nov.
29, to $24.22. The world’s largest consumer-electronics retailer
posted a same-store sales drop in December that was in line with
analysts’ estimates and repeated its forecast for profit this
year as it fought off challenges from Amazon.com Inc. and Wal-
Mart Stores Inc.  Dendreon Corp. (DNDN)   had the biggest gain in the
Russell 1000 Index, adding 16 percent to $12.35. The maker of
the prostate-cancer drug Provenge increased for a second day on
optimism sales of the company’s only product will increase after
revenue more than tripled in the fourth quarter.  Durect Corp. (DRRX)   fell the most in the Russell 2000
Index, slumping 38 percent to 74 cents. The maker of drug-
delivery systems said results from a clinical trial of Posidur,
a post-surgery pain relief depot, didn’t reach statistical
significance.  Exide Technologies (XIDE)   climbed 11 percent, the most
since Nov. 30, to $3.13. The producer of lead-acid batteries was
raised to “outperform” from “neutral” at Wedbush Securities.  Family Dollar Stores Inc. (FDO)   fell 7.5 percent, the
most since January 2011, to $53.63. The discount retailer
reported fiscal first-quarter revenue of $2.15 billion, missing
the average analyst estimate of $2.17 billion. Comparable store
sales increased 4.1 percent, compared with the average analyst
estimate of 4.9 percent.  Greenbrier Cos. (GBX)   jumped 8.4 percent to $25.89, the
highest price since May 31. The railcar producer reported first-
quarter earnings of 48 cents a share, compared with a net loss
of 11 cents a share a year earlier.  Integra LifeSciences Holdings Corp. (IART)   sank 20
percent, the most since March 1997, to $24.49. U.S. regulators
cited the maker of orthopedic implants and skin-graft materials
for burn victims for a problem with mold at it factory. The
company also reported preliminary fourth-quarter revenue of $203
million at most, below the average analyst estimate of $213
million.  Jazz Pharmaceuticals Inc. (JAZZ)   gained 9.5 percent, the
most since Aug. 23, to $45.39. The drugmaker said earnings in
2012 will be as much as $4.15 a share, compared with the average
analyst estimate of $3.39. The forecast reflects earnings after
the company completes the acquisition of Azur Pharma.  PriceSmart Inc. (PSMT)   dropped 14 percent, the most
since December 2008, to $60.63. The owner of warehouse-shopping
clubs reported first-quarter earnings that missed analysts’
estimates.  Regeneron Pharmaceuticals Inc. (REGN)   rose 8 percent to
$65.79, the highest price since Oct. 10. The drugmaker was
boosted to “buy” from “hold” at Jefferies Group Inc.  RF Micro Devices Inc. (RFMD)   sank 20 percent, the most
since December 2008, to $4.54. The U.S. maker of chips and radio
systems for mobile phones cut its forecast for fiscal third-
quarter revenue to $225 million, compared with a previous
estimate of $250 million. The company was cut to “market
perform” from “outperform” at Oppenheimer & Co.  Saba Software Inc. (SABA)   rallied 16 percent, the most
since April 2009, to $8.57. The maker of computer programs used
by corporations to train employees named Elaine Kitagawa chief
financial officer. Kitagawa previously served as CFO at Gaia
Interactive, the company said.  Synta Pharmaceuticals Corp. (SNTA)   fell 15 percent, the
most since January 2011, to $4.39. The drugmaker said it’s
offering 7 million shares at $4.40 each.  United Community Banks Inc. (UCBI)  (UCBI US) fell 10 percent, the
most since Aug. 10, to $6.49. The regional bank, which has
branches in  Georgia  and  North Carolina , was lowered to “hold”
from “buy” by equity analyst Kevin Fitzsimmons at Sandler
O’Neill & Partners LP, with a 12-month price estimate of $7 a
share.  To contact the reporter on this story:
Katia Porzecanski in New York at 
 kporzecansk1@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  